XT
HBIO icon

XTX Topco’s Harvard Bioscience HBIO Stock Holding History

XTX Topco’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,935
Closed -$26.3K – 4038
2025
Q4 		$26.3K Buy
+3,935
New +$23.3K ﹤0.01% 3001
2025
Q3 		– Sell
-1,113
Closed -$4.94K – 2834
2025
Q2 		$4.94K Buy
+1,113
New +$4.65K ﹤0.01% 2257
2023
Q4 		– Sell
-1,332
Closed -$57.3K – 1790
2023
Q3 		$57.3K Sell
1,332
-174
-12% -$8.03K 0.01% 1260
2023
Q2 		$82.7K Buy
+1,506
New +$82.6K 0.01% 1183
2022
Q3 		– Sell
-3,280
Closed -$118K – 1211
2022
Q2 		$118K Buy
+3,280
New +$148K 0.05% 608

Other funds holding HBIO

WCM
Weber Capital Management San Francisco, California $100M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return